These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 29235704)

  • 1. Industry-Academia Partnership: The Synthesis and Solid-State Pharmaceutical Centre (SSPC) as a Collaborative Approach from Molecule to Medicine.
    McGlacken GP; Hayes S; Maguire AR; O'Halloran J; Hodnett K
    Chemistry; 2018 Jan; 24(2):499-503. PubMed ID: 29235704
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Collaborative practices for medicinal chemistry research across the big pharma and not-for-profit interface.
    Andrews DM; Swarbrick ME; Merritt AT
    Drug Discov Today; 2014 Apr; 19(4):496-501. PubMed ID: 24486295
    [TBL] [Abstract][Full Text] [Related]  

  • 3. No Denying It: Medicinal Chemistry Training Is in Big Trouble.
    Rafferty MF
    J Med Chem; 2016 Dec; 59(24):10859-10864. PubMed ID: 27668824
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Collaborations among academia, government, and industry in the diagnostics space: barriers and some ideas for solutions.
    Evans G; Austin F
    Sci Transl Med; 2010 Dec; 2(63):63mr3. PubMed ID: 21178133
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Achieving continuous manufacturing: technologies and approaches for synthesis, workup, and isolation of drug substance. May 20-21, 2014 Continuous Manufacturing Symposium.
    Baxendale IR; Braatz RD; Hodnett BK; Jensen KF; Johnson MD; Sharratt P; Sherlock JP; Florence AJ
    J Pharm Sci; 2015 Mar; 104(3):781-91. PubMed ID: 25470351
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drugs, industry, and academia.
    Fitzgerald GA
    Science; 2008 Jun; 320(5883):1563. PubMed ID: 18566251
    [No Abstract]   [Full Text] [Related]  

  • 7. [Early achievements of the Danish pharmaceutical industry-7].
    Grevsen JV; Kirkegaard H; Kruse E; Kruse PR
    Theriaca; 2014; (42):31-62. PubMed ID: 25816561
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Drug Discovery Portal: a resource to enhance drug discovery from academia.
    Clark RL; Johnston BF; Mackay SP; Breslin CJ; Robertson MN; Harvey AL
    Drug Discov Today; 2010 Aug; 15(15-16):679-83. PubMed ID: 20547242
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery of PET radiopharmaceuticals at the academia-industry interface.
    Bernard-Gauthier V; Collier TL; Liang SH; Vasdev N
    Drug Discov Today Technol; 2017 Nov; 25():19-26. PubMed ID: 29233263
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Looking forward in pharmaceutical process chemistry.
    Davies IW; Welch CJ
    Science; 2009 Aug; 325(5941):701-4. PubMed ID: 19661417
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fundamental problems lie ahead in the drug discovery and commercialization process: restructuring of the pharmaceutical industry and an improved partnership with academia are required.
    Brewer GJ
    J Investig Med; 2006 Sep; 54(6):291-302. PubMed ID: 17191351
    [No Abstract]   [Full Text] [Related]  

  • 12. Ask the experts: future of the pharmaceutical industry. Interview by Future Medicinal Chemistry.
    Cottens S; Eaton M; Fuhr J; Geary S; Johnson DS; Li G; Raveglia L; Robertson GM; Westwell A
    Future Med Chem; 2011 Nov; 3(15):1863-72. PubMed ID: 22023030
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Translation of innovative chemistry into screening libraries: an exemplar partnership from the European Lead Factory.
    Morgentin R; Dow M; Aimon A; Karageorgis G; Kalliokoski T; Roche D; Marsden S; Nelson A
    Drug Discov Today; 2018 Sep; 23(9):1578-1583. PubMed ID: 29753124
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Early achievements of the Danish pharmaceutical industry-6 Pharmacia].
    Grevsen JV; Kruse E; Kruse PR
    Theriaca; 2014; (42):9-30. PubMed ID: 25816560
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug discovery chemistry: a primer for the non-specialist.
    Jordan AM; Roughley SD
    Drug Discov Today; 2009 Aug; 14(15-16):731-44. PubMed ID: 19416759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The future of discovery chemistry: quo vadis? Academic to industrial--the maturation of medicinal chemistry to chemical biology.
    Hoffmann T; Bishop C
    Drug Discov Today; 2010 Apr; 15(7-8):260-4. PubMed ID: 20149893
    [TBL] [Abstract][Full Text] [Related]  

  • 17. History and Prospects of Drug Discovery and Development Collaboration between Industry and Academia.
    Singh SB; Martin GE; McKittrick B; Crowther J; Fraenkel H; Lunn C; Bayne M; Perkins JB; Gullo V
    J Nat Prod; 2024 Apr; 87(4):1235-1245. PubMed ID: 38554098
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Creating effective medicinal chemistry collaborations in drug discovery.
    Giardina GA; Raveglia LF
    Future Med Chem; 2009 Apr; 1(1):3-6. PubMed ID: 21426065
    [No Abstract]   [Full Text] [Related]  

  • 19. Industry Perspective on Biomarker Development and Qualification.
    Gerlach CV; Derzi M; Ramaiah SK; Vaidya VS
    Clin Pharmacol Ther; 2018 Jan; 103(1):27-31. PubMed ID: 29143971
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interview with Graham Warrellow by Isaac Bruce.
    Warrellow G
    Future Med Chem; 2012 Jun; 4(9):1047-51. PubMed ID: 22709249
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.